Reach Us +44-1202-068036
Ian P. Everall | OMICS International
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ian P. Everall

Department of Psychiatry
University of Melbourne


 Professor Ian Everall obtained his MBChB at Leicester University School of Medicine. He trained in psychiatry at the Bethlem royal and Maudsley Hospitals, London. In 1989 he obtained Membership of the Royal College of Psychiatrists and a MRC Clinical Research Training Fellowship, followed in 1992 by an advanced MRC Clinician Scientist Fellowship in the Department of Neuropathology, Institute of Psychiatry. He obtained his PhD in 1992. In 1993 he was appointed Senior Lecturer at the Institute of Psychiatry and Honorary Consultant Psychiatrist at The Maudsley Hospital. In 1999 he was appointed Professor of Psychiatry at the University of California, San Diego. At the end of 2009 Professor Everall took up the role of Cato Chair and Head of Department of Psychiatry, University of Melbourne. 

Research Interest

 Professor  Everall has been at the forefront of research into cellular, molecular and genetic changes in the brain in major psychiatric disorders for over twenty years. His area of interest includes psychosis, major depression, bipolar disorder and cognitive impairment, especially when associated with HIV infection and methamphetamine use which is becoming a growing social and psychiatric concern globally. Professor Everall is currently working on research into blood based biomarkers to aid in the diagnosis of psychosis and autism spectrum disorder, and further refining the molecular neuropathology of schizophrenia   


Global Speakers in the subject

Global Experts in the subject